OmniAb Shares Outstanding vs. Total Debt
| OABI Stock | USD 3.92 0.07 1.82% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.63 | 0.4293 |
|
|
For OmniAb profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OmniAb to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OmniAb Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OmniAb's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OmniAb Inc over time as well as its relative position and ranking within its peers.
OmniAb |
OmniAb's Revenue Breakdown by Earning Segment
Check out Your Equity Center.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OmniAb. If investors know OmniAb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OmniAb listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.202 | Quarterly Revenue Growth (0.24) | Return On Assets (0.14) | Return On Equity (0.20) |
The market value of OmniAb Inc is measured differently than its book value, which is the value of OmniAb that is recorded on the company's balance sheet. Investors also form their own opinion of OmniAb's value that differs from its market value or its book value, called intrinsic value, which is OmniAb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OmniAb's market value can be influenced by many factors that don't directly affect OmniAb's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OmniAb's value and its price as these two are different measures arrived at by different means. Investors typically determine if OmniAb is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OmniAb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
OmniAb Inc Total Debt vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining OmniAb's current stock value. Our valuation model uses many indicators to compare OmniAb value to that of its competitors to determine the firm's financial worth. OmniAb Inc is regarded third in shares outstanding category among its peers. It is rated below average in total debt category among its peers making up about 0.21 of Total Debt per Shares Outstanding. The ratio of Shares Outstanding to Total Debt for OmniAb Inc is roughly 4.73 . The current Total Debt To Capitalization is estimated to decrease to 0.01. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OmniAb's earnings, one of the primary drivers of an investment's value.OmniAb Total Debt vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
OmniAb |
| = | 121.01 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
OmniAb |
| = | 25.56 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
OmniAb Total Debt vs Competition
OmniAb Inc is rated below average in total debt category among its peers. Total debt of Health Care industry is now estimated at about 708.06 Million. OmniAb holds roughly 25.56 Million in total debt claiming about 4% of equities under Health Care industry.
OmniAb Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in OmniAb, profitability is also one of the essential criteria for including it into their portfolios because, without profit, OmniAb will eventually generate negative long term returns. The profitability progress is the general direction of OmniAb's change in net profit over the period of time. It can combine multiple indicators of OmniAb, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 50 K | 47.5 K | |
| Net Interest Income | 4.5 M | 4.7 M | |
| Operating Income | -69.4 M | -65.9 M | |
| Net Loss | -29.7 M | -31.2 M | |
| Income Before Tax | -64.4 M | -61.1 M | |
| Total Other Income Expense Net | 5.1 M | 5.3 M | |
| Net Loss | -20.1 M | -21.1 M | |
| Net Loss | -50.6 M | -48.1 M | |
| Income Tax Expense | -13.7 M | -13.1 M | |
| Interest Income | 4.5 M | 4.7 M | |
| Change To Netincome | 13 M | 7.9 M | |
| Net Loss | (0.51) | (0.53) | |
| Income Quality | (0.05) | (0.04) | |
| Net Income Per E B T | 0.79 | 0.92 |
OmniAb Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on OmniAb. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OmniAb position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OmniAb's important profitability drivers and their relationship over time.
Use OmniAb in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OmniAb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OmniAb will appreciate offsetting losses from the drop in the long position's value.OmniAb Pair Trading
OmniAb Inc Pair Trading Analysis
The ability to find closely correlated positions to OmniAb could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OmniAb when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OmniAb - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OmniAb Inc to buy it.
The correlation of OmniAb is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OmniAb moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OmniAb Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OmniAb can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your OmniAb position
In addition to having OmniAb in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
To fully project OmniAb's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of OmniAb Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include OmniAb's income statement, its balance sheet, and the statement of cash flows.